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ABSTRACT
Objectives: To evaluate the serum 25-hydroxyvitamin D [25(OH)D] concentration in Brazilian oste-
oporotic patients and the modifiable factors of vitamin D status in this population. Subjects and 
methods: In a cross-sectional study, 363 community-dwelling patients who sought specialized 
medical care were evaluated between autumn and spring in São Paulo, Brazil. Serum levels of 
25(OH)D and parathormone (PTH), biochemical and anthropometric measurements, and bone 
density scans were obtained. The group was assessed using two questionnaires: one question-
naire covered lifestyle and dietary habits, skin phototype, sun exposure, medical conditions, and 
levels of vitamin D supplementation (cholecalciferol); the other questionnaire assessed health-
-related quality-of-life. Logistic regression and a decision tree were used to assess the association 
between the variables and the adequacy of vitamin D status. Results: The mean age of the overall 
sample was 67.9 ± 8.6 years, and the mean 25(OH)D concentration was 24.8 ng/mL. The prevalen-
ce of inadequate vitamin D status was high (73.3%), although 81.5% of the subjects were receiving 
cholecalciferol (mean dose of 8,169 IU/week). 25(OH)D was positively correlated with femoral 
neck bone mineral density and negatively correlated with PTH. In the multivariate analysis, the 
dose of cholecalciferol, engagement in physical activity and the month of the year (September) 
were associated with improvement in vitamin D status. Conclusions: In this osteoporotic popu-
lation, vitamin D supplementation of 7,000 IU/week is not enough to reach the desired 25(OH)
D concentration (≥ 30 ng/mL). Engagement in physical activity and the month of the year are 
modifiable factors of the vitamin D status in this population. Arq Bras Endocrinol Metab. 2014;58(5):572-82
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ReSumo
Objetivos: Avaliar a concentração sérica de 25-hidroxivitamina D [25(OH)D] em pacientes osteo-
poróticos brasileiros e os fatores modificáveis do status de vitamina D nesta população. Sujeitos 
e métodos: Em um estudo transversal, 363 pacientes, residentes na comunidade, que procura-
vam atendimento médico especializado, foram avaliados entre o outono e a primavera, em São 
Paulo, Brasil. Níveis séricos de 25(OH)D e paratormônio (PTH), avaliações bioquímicas e antropo-
métricas e exames de densitometria óssea foram obtidos. O grupo foi avaliado por meio de dois 
questionários: um questionário abordou estilo de vida e hábitos alimentares, fototipo de pele, ex-
posição solar, problemas médicos e os níveis de suplementação de vitamina D (colecalciferol); o 
outro questionário avaliou a qualidade de vida relacionada à saúde. Regressão logística e árvore 
de decisão foram utilizadas para avaliar a associação entre as variáveis e a adequação do status 
de vitamina D. Resultados: A idade média da amostra foi de 67,9 ± 8,6 anos e a concentração 
média de 25(OH)D foi de 24,8 ng/mL. A prevalência de um status de vitamina D inadequado foi 
elevada (73,3%), apesar de 81,5% dos indivíduos receberem colecalciferol (dose média de 8.169 
UI/semana). 25(OH)D correlacionou-se positivamente com a densidade mineral óssea do colo de 
fêmur e negativamente com PTH. Nas análises multivariadas, a dose de colecalciferol, a prática 
de exercícios físicos e o mês do ano (setembro) foram associados com a melhora do status de vi-
tamina D. Conclusões: Nesta população osteoporótica, a suplementação de 7.000 UI/semana não 
é suficiente para atingir a concentração desejada de 25(OH)D (≥ 30 ng/mL). A prática de exercícios 
físicos e o mês do ano são fatores modificáveis do status de vitamina D na população estudada. 
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INTRoDuCTIoN
T he central role of vitamin D in bone health and muscle function has long been acknowledged, 
and evidence suggests that adequate vitamin D sta-
tus is essential for the management of osteoporosis 
(1-4). Controversy exists regarding the optimum 
level of serum 25-hydroxyvitamin D [25(OH)D] in 
a healthy population. However, most experts agree 
that a serum 25(OH)D concentration of at least 30 
ng/mL is the endpoint for skeletal health outcomes 
(1,2,5). Inadequate vitamin D status induces secon-
dary hyperparathyroidism, which stimulates bone loss 
and subsequently increases the risk of osteoporosis 
and fractures (6). Exposure to sunlight, which indu-
ces vitamin D synthesis in the skin, is an important 
determinant of vitamin D status, and several studies 
have shown that its production is influenced by a va-
riety of factors, including skin pigmentation, clothing 
style, season and air pollution, among others (7-10). 
Serum 25(OH)D concentration decreases with incre-
asing age and body mass index (BMI) and increases 
with increasing intake of vitamin D and physical acti-
vity (5,8,9). 
In Brazil, a country with a sunny climate, a proper 
amount of 25(OH)D in the population would be ex-
pected. However, a survey among Brazilian adults reve-
aled high prevalence rates of hypovitaminosis D in the 
winter and in the summer (77% and 37%, respectively) 
(5). Similarly, an 86% prevalence rate of inadequate vi-
tamin D status was reported in Brazilian postmenopau-
sal women receiving vitamin D supplementation of 400 
IU/day (11). By contrast, a lower prevalence of hypo-
vitaminosis D was observed in elderly Brazilian practi-
tioners of outdoor physical activities (7% in the summer 
and 19% in the winter) (9).
Because inadequate vitamin D status is a health 
problem worldwide, identifying modifiable factors of 
vitamin D status has clinical relevance (10,12). The 
aims of our study were, firstly, to evaluate the 25(OH)
D concentration and the prevalence of hypovitaminosis 
D in Brazilian osteoporotic patients who were seeking 
specialized medical care. Secondly, we examined the 
clinical and nutritional profile of these patients and po-
tential modifiable factors of vitamin D status, including 
levels of vitamin D supplementation and lifestyle habits. 
Thirdly, we attempted to identify whether vitamin D 
status influences muscle strength and functional ability 
in these patients.
SuBJeCTS AND meTHoDS
This cross-sectional study evaluated 363 community-
-dwelling patients who attended a specialized outpa-
tient clinic of the Federal University of São Paulo. 
Postmenopausal women over the age of 45 (absence 
of menses for a minimum of 2 years) and men older 
than 50 who were undergoing osteoporosis treatment 
for at least 3 months were eligible to participate. Oste-
oporosis was defined as a bone mineral density (BMD) 
T-score at the distal radius, femoral neck, total hip and/
or lumbar spine ≤ -2.5 SD, as well as a BMD T-score 
between -1.0 and -2.5 SD at any of these sites, in addi-
tion to a history of low-trauma, fragility fractures of 
the hip, spine or wrist after the age of 45 (13,14). En-
rollment occurred between late autumn and late spring 
in 2009, 2010 and 2011. All of the subjects formerly 
received or were receiving treatment for osteoporosis 
with any approved osteoporosis medication, including 
calcium and vitamin D supplementation. 
The study protocol was approved by the University 
Research Ethics Committee, and written consent was 
obtained from all of the participants. 
Fasting samples of blood and urine were obtained 
from the patients, and the samples were kept frozen at 
-20°C until the analyses were performed. Height and 
weight were recorded. A trained physician assessed the 
group using a standard questionnaire and a health-rela-
ted quality-of-life questionnaire (the Health Assessment 
Questionnaire Disability Index – HAQ-DI) (15). Bone 
density and body composition were assessed using du-
al-energy X-ray absorptiometry (DXA). Muscle streng-
th tests were performed to measure hand-grip strength, 
hip flexor strength and knee extensor strength. 
Laboratory measurements
Serum total calcium (Ca), phosphorus (P), albumin 
(Alb) and urine calcium (UCa) were measured using 
the colorimetric method; Ca was adjusted for Alb con-
centration (16). Urine creatinine (UCr) and serum cre-
atinine were measured using the kinetic colorimetric 
method. Creatinine clearance (ClCr) was calculated 
using the Cockcroft-Gault equation. The UCa-UCr 
ratio was calculated. Aspartate aminotransferase (AST), 
alanine aminotransferase (ALT) and alkaline phospha-
tase (ALP) were measured using an enzymatic method. 
C-terminal telopeptide of collagen type I (CTX-I) and 
total procollagen type 1 amino-terminal propeptide 
(P1NP) as well as parathormone (PTH) were measu-
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red using commercial kits (chemoluminescence, Roche, 
Elecsys 2010 analyzer, USA). For CTX-I, the intra-assay 
and inter-assay coefficients of variation (CVs) were 4.6% 
and 4.7%, respectively; for PINP, the intra-assay and in-
ter-assay CVs were 1.8% and 2.7%, respectively; and for 
PTH, the intra-assay and inter-assay CVs were 3.0% and 
3.5%, respectively. Total 25(OH)D was evaluated using 
a commercial chemiluminescent immunoassay method 
(DiaSorin, Liaison analyzer, USA) with intra-assay and 
inter-assay CVs of 1.6% and 5.6%, respectively.
Anthropometrics
Weight and height were measured using a digital scale 
and a wall-mounted stadiometer, respectively. BMI was 
calculated and categorized according to the World He-
alth Organization classification (17).
Standard questionnaire
The participants were asked about their age, age of me-
nopause, place of residence, level of education, and the 
following factors (highlighted in italics):
Fractures that occurred after falls after the age of 45 
and in the past 5 years, as well as the fracture sites, were 
recorded.
The subjects were categorized into those who enga-
ged in some form of regular physical exercise (any regu-
lar exercise for a minimum of 30 minutes per time) and 
those who did not. The amount of exercise per week 
was categorized as 1 or 2 times, 3-5 times or ≥ 6 times.
Smoking: the subjects were classified as smokers or 
non-smokers; the non-smoking group comprised peo-
ple who said they had never smoked or had smoked at 
some stage in their lives. 
Medical conditions related to low bone mass and vi-
tamin D inadequacy were recorded.
The use of concurrent medications within the last 3 
months was recorded, including any bone-related the-
rapy, such as bisphosphonates, raloxifene, teriparatide 
and hormone replacement therapy, and medications 
that could potentially affect bone mineral metabolism, 
such as glucocorticoids and anticonvulsants. The use of 
calcium and vitamin D supplements was also recorded.
The participants were categorized according to their 
skin phototype (Fitzpatrick classification). Non-black skin 
types are classified as “I” to “IV”, and black skin types 
are classified as “V” and “VI” (18,19).
Use of sunscreen: the subjects were classified as usual 
users or non-users of sunscreen according to their own 
evaluation.
Sun exposure was measured with the sun index (SI). 
The SI corresponds to the number of hours per week 
spent outside without sun protection multiplied by the 
percentage of the body exposed to sunlight (9% for 
face, 1% for each hand, 9% for each arm and 18% for 
each leg) (13). 
Calcium and vitamin D intake were assessed by 
analyzing the patients’ dietary records. The participants 
were oriented to register their food intake for a period 
of 3 alternate days, including 2 weekdays and 1 weekend 
day. Initially, the intake amounts were measured using ho-
memade measures, and these values were later converted 
into kilograms and into macronutrient and micronutrient 
amounts. The data were analyzed using the Nutrition 
Data System for Research software (version 2007; NDS-R, 
University of Minnesota, Minneapolis, MN, USA). 
HAQ-DI
The HAQ-DI consists of 20 questions that cover ac-
tivities of daily life, such as dressing, rising, eating, 
walking, performing hygiene activities, reaching, grip-
ping, and performing ordinary activities. According to 
the answers, the patients were classified as having mild 
to moderate difficulty, moderate to severe disability or 
severe to very severe disability (15,20).
muscle strength tests
Blood pressure and the skin condition of the lower limbs 
were verified before beginning the tests, which were 
not performed on patients with high blood pressure 
(systolic ≥ 170 mmHg and/or diastolic ≥ 100 mmHg), 
pain, limb immobilization, varicose veins or paresis or 
on patients who refused. The grip strength of both the 
right and left hands was measured using a hand-grip 
dynamometer (Analogue Dial – A5001, Takei, Japan). 
The maximum isometric strength of the hip flexor and 
knee extensor on the subjects’ dominant limb was tes-
ted using a portable mechanical dynamometer (model 
01163; Manual Lafayette Muscle Test System, USA) as 
described elsewhere (21). 
DXA measurements
The lumbar spine (LS) at L1-L4, total femur (TF), fe-
moral neck (FN) and body composition (total fat and 
lean body mass and total body BMD) were measured 
using DXA (Discovery A, QDR for Windows XP, Ho-
logic, USA). BMD was assessed and analyzed accor-
ding to the recommendations of the Brazilian Society 
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for Clinical Densitometry (14). The whole body DXA 
exams were conducted in accordance with the procedu-
res recommended by the manufacturer (Hologic, Inc., 
Bedford, MA) (22). The CV was 0.8% for the LS and 
the TF and 1.2% for the FN. The variability (CV) for 
total fat and lean body mass and total body BMD from 
Hologic QDR DXA instruments ranges from 1.2-3.2%, 
0.6-2.2% and 1.0-1.8%, respectively (23,24).
Statistical analysis
For all of the statistical analysis, we used the SPSS, ver-
sion 17.0 (USA). The numerical variables were des-
cribed with medians, means and standard deviations 
(SDs), and the categorical variables were described with 
absolute and relative frequencies. The associations be-
tween the categorical variables were verified using the 
chi-square test or Fisher’s exact test, as appropriate. The 
quantitative variables of 2 groups were compared using 
Student’s t-test or the Mann-Whitney test, as appro-
priate. For comparing more than 2 groups, the Kruskal-
-Wallis nonparametric test was used. After the differences 
between the groups were detected, subsequent Mann-
-Whitney tests were conducted to locate the differen-
ces; the Bonferroni correction was applied to maintain 
the level of global significance. Subsequently, we used 
Pearson’s linear correlation to establish the association 
between 25(OH)D and the quantitative variables. The 
partial correlation was used to assess the associations be-
tween 25(OH)D and the FN T-score, the FN BMD and 
the total body BMD after controlling for the physical 
activity variable. Odds ratios (OR, with 95% CI) were 
determined using binary logistic regression (backward 
method). A decision tree was also produced as a form of 
multivariate analysis: the algorithm employed was Chi-
-square Automatic Interaction Detection.
There were no significant differences between the se-
xes in 25(OH)D concentration, age, BMI, lifestyle and 
dietary habits, skin phototype or sun exposure. Thus, 
both sexes were considered together in the analyses of 
the associations between 25(OH)D and the quantitati-
ve variables as well as in the multivariate analyses.
For all of the statistical tests, the results were consi-
dered significant when p < 0.05.
ReSuLTS
Figure 1 shows the prevalence of inadequate vitamin 
D status according to various cut-off points for the 
25(OH)D concentration.
The sample comprised primarily of women (n = 
343; 94.5%). The metropolitan area of São Paulo (n 
= 353; 97.2%) was the main place of residence repor-
ted. Overall, 13.5% of the participants (n = 49) met 
the criteria for obesity (BMI ≥ 30 kg/m2). The mean 
age of menopause was 45.9 ± 6.1 years, and the mean 
time between menopause and the study was 21.8 years 
(range 2.0 – 48.0 years). 
The food records were completed by 45% of the 
participants (154 women and 9 men). Excluding su-
pplemental intake, the average daily calcium consump-
tion was 808 ± 362 mg, and the average daily vitamin 
D intake was 173 ± 92 IU. The median intake of die-
tary calcium was 751 mg/day in women and 595 mg/
day in men, and the median intake of dietary vitamin D 
was 155 IU/day in women and 112 IU/day in men. 
There was no significant difference between the gen-
ders in the energy consumed (kcal/day) or in the daily 
consumption of calcium or vitamin D (Mann-Whitney, 
p = 0.320, p = 0.561, and p = 0.495, respectively).
Table 1 shows the summary measures of age, BMI, 
laboratory evaluations, supplemental dose of calcium/
vitamin D and DXA results of the study population as a 
whole and according to gender. 
In table 2, the characteristics of the population are 
shown. 
Seventy-four patients (20.4%) reported experien-
cing one or more clinical fractures of the wrist, hip 
and/or spine after the age of 45. Fifty-seven patients 
(15.7%) reported one (n = 45) or more fractures (n = 
12) related to a fall within the past 5 years. The most 
common fracture site related to a fall was the wrist (n = 
18), followed by the foot (n = 9), the hip (n = 7) and 
the ankle (n = 5). 
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Figure 1. Vitamin D status: distribution of the population, according to the 
cut-off points for serum 25(OH)D levels.
Modifiable factors of vitamin D status
Co
py
rig
ht
©
 A
BE
&
M
 to
do
s o
s d
ire
ito
s r
es
er
va
do
s.
576 Arq Bras Endocrinol Metab. 2014;58/5
Table 1. Clinical and laboratory parameters of the study population 
Variable
Whole group Female male
Comparison
Between 
Sexes
n median minimum maximum n median minimum maximum n median minimum maximum p value
Age, years 363 68.0 47.0 87.0 343 68.0 47.0 87.0 20 68.0 54.0 84.0 0.922*
BMI, kg/m2 363 25.6 16.6 42.8 343 25.6 16.6 42.8 20 26.8 19.3 36.4 0.208
25(OH)D, ng/mL
(1)
363 23.1 6.4 94.6 343 23.0 6.4 94.6 20 25.9 10.9 46.7 0.486
PTH, pg/mL
(2)
363 52.4 12.4 176.8 343 52.2 12.4 176.8 20 52.8 28.7 133.0 0.588
PINP, ng/mL
(3)
363 22.5 5.0 180.4 343 22.5 5.0 180.4 20 15.3 6.5 171.9 0.234
CTX-I, ng/mL
(4)
363 0.147 0.010 1.270 343 0.148 0.010 1.270 20 0.113 0.010 0.583 0.354
Alb, g/dL
(5)
363 4.3 3.1 5.0 343 4.3 3.1 5.0 20 4.3 3.6 4.8 0.270
ClCr, mL/min
(6)
363 66 26 153 343 66.0 26 153 20 67.0 46.0 121.0 0.526
Ca, mg/dL
(7)
363 9.3 8.0 10.7 343 9.3 8.0 10.7 20 9.1 8.6 10.3 0.425
P, mg/dL
(8)
363 3.5 1.9 4.8 343 3.5 2.0 4.8 20 3.2 1.9 3.8 < 0.001
AST, U/L
(9)
363 20.0 11 55 343 20.0 11.0 55.0 20 21.0 15.0 31.0 0.652
ALT, U/L
(10)
363 13.0 4 54 343 13.0 4 54 20 16.0 8.0 46.0 0.041
ALP, U/L
(11)
363 62.0 19 420 343 62.0 19 420 20 54.3 32.0 84.0 0.092
UCa/UCr
(12)
362 0.079 0.002 0.481 342 0.079 0.003 0.481 20 0.068 0.002 0.194 0.551
Cholecalciferol, IU/week 296 7,000 400 83,333 281 7,000 400 83,333 15 7,000 5,000 21,000 1.000
Calcium suppl., mg/day 202 500 178 1500 189 500 178 1500 13 500 500 1000 0.261
T-score LS 344 -2.8 -6.1 1.2 325 -2.8 -6.1 0.6 19 -2.4 -5.7 1,2 0.237
T-score FN 347 -1.8 -4.0 1.2 329 -1.8 -4.0 1.2 18 -2.0 -3.0 -0.8 0.937
T-score TH 347 -1.6 -4.9 0.7 329 -1.6 -4.9 0.7 18 -1.5 -2.7 -0.2 0.565
Total body BMD, g/cm2 332 0.933 0.691 1.352 314 0.928 0.691 1.352 18 1.024 0.891 1.227 < 0.001
Fat mass, % 332 35.4 15.8 49.0 314 35.7 15.8 49.0 18 25.0 17.8 33.7 < 0.001
Lean mass, g 332 37,010 24,441 67,018 314 36,402 24,441 47,929 18 49,733 39,083 67,018 < 0.001
The nonparametric Mann-Whitney test was used to compare data between the groups, except for the comparison of age (*Student’s t-test).
Reference values: (1) 30-100 ng/mL; (2) 15-65 pg/mL; (3) female median 37.09 ng/mL (5-95thpercentile, 16.27-73.87 ng/mL); (4) female, post menopause, 0.556 ± 0.226 ng/mL; male, 50-70 
yr, 0.304 ± 0.200 ng/mL; male > 70 yr, 0.394 ± 0,230 ng/mL (5) 3.2-5.6 g/dL; (6) ≥ 60 mL/min; (7) 8.5-10.5 mg/dL; (8) 2.5-4.5 mg/dL; (9) up to 32 U/L; (10) up to 31 U/L; (11) 50-250 U/L; (12) 
< 0.210.
Diabetes and hypertension were reported by 
16.8% and 57.3% of participants, respectively. Thirty-
-nine participants (10.7%) had chronic lung diseases 
such as asthma and chronic obstructive pulmonary di-
sease. Fifty participants (13.8%) reported at least one 
medical condition known to affect the adequacy of vi-
tamin D status, such as chronic liver disease (n = 10), 
intestinal malabsorption (n = 7), gastric surgery (n = 
3), the use of anticonvulsants (n = 4), the use of glu-
cocorticoids (n = 18), primary hyperparathyroidism 
(n = 6), or more than 2 of these medical conditions 
(n = 2).
The majority of the participants (81.5%) were re-
ceiving vitamin D supplementation (cholecalciferol) 
as well as bisphosphonate treatment (75.5%). Twenty-
-six participants (7.2%) were receiving treatment with 
raloxifene or hormone replacement therapy, and 3 
participants (0.8%) were receiving treatment with te-
riparatide. In the overall sample (n = 363), the mean 
cholecalciferol dose was 8,169 IU/week. Considering 
only the participants using cholecalciferol (n = 296), 
the mean dose varied according to vitamin D status: 
for a 25(OH)D concentration < 20.0 ng/mL (n = 94), 
the mean dose was 8,723 ± 4,586 IU/week; and for 
a 25(OH)D concentration from 20.0 to 29.9 ng/mL 
(n = 112), the mean dose was 8,560 ± 3,830 IU/
week. The cholecalciferol dose was significantly higher 
only for the patients with 25(OH)D ≥ 30.0 ng/mL 
(n = 90), namely, 13,185 ± 12,618IU/week (Kruskal-
-Wallis, p < 0.001). There was no relationship between 
vitamin D status and the presence or absence of diseases 
such as diabetes (c2 = 1.49, p = 0.475), hypertension 
(c2 = 0.35, p = 0.840) and chronic lung disease (c2 = 
1.67, p = 0.435).
The mean 25(OH)D concentrations did not differ 
among the groups according to sex, age (< 60 years 
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Table 2. General characteristics of the study population
Characteristics
Whole Group
n %
Highest level of education 363 100.0
Illiteracy/reading and writing 44 12.1
Up to elementary school 239 65.8
Up to high school 55 15.2
Up to university 25 6.9
Sunscreen use 363 100.0
Yes 130 35.8
No 233 64.2
Skin phototype 363 100.0
Type I 7 1.9
Type II 79 21.8
Type III 174 47.9
Type IV 87 24.0
Type V and VI 16 4.4
BmI (kg/m2) 363 100.0
< 18.5 9 2.5
18.5-24.9 156 43.0
25.0-29.9 149 41.0
≥ 30.0 49 13.5
HAQ-DI 362 100.0
Mild to moderate difficulty 283 78.2
Moderate to severe disability 67 18.5
Severe to very severe disability 12 3.3
Sun exposure index (#) 363 100.0
≤ 2.03 285 78.5
> 2.03 78 21.5
# SI of 2.03, for example, corresponds to having one’s face, arms and hands exposed to the 
sun without protection for 7h a week.
old, 61-70 years old and > 70 years old), BMI, skin 
phototype, HAQ-DI score, SI (≤ 2.03 and > 2.03), use 
of sunscreen (yes/no), history of medical conditions known 
to affect the adequacy of vitamin D status (yes/no) 
and history of fractures (yes/no). The serum 25(OH)
D concentration was also compared across SI quarti-
les, and no difference was observed (Kruskal-Wallis, 
p = 0.916). Table 3 shows the factors associated with 
higher 25(OH)D concentrations: engagement in phy-
sical activity, vitamin D supplementation, not-smoking, 
and a PTH concentration in the normal range. As ex-
pected, the participants who had their blood drawn in 
August had lower 25(OH)D concentrations compared 
with the June and September groups.
The serum 25(OH)D concentration had weak but 
significant correlations with the cholecalciferol dose 
(r = 0.272, p < 0.001), the FN T-score (r = 0.141, p 
= 0.009), FN BMD (r = 0.138, p = 0.010) and total 
body BMD (r = 0.141, p = 0.010) and a negative cor-
relation with PTH (r = -0.138, p = 0.009). Even after 
controlling for physical activity, serum 25(OH)D still 
maintained positive correlations with the FN T-score (r 
= 0.148, p = 0.007), FN BMD (r = 0.145, p = 0.008) 
and total body BMD (r = 0.145, p = 0.008). The cor-
relations between 25(OH)D and the muscle strength 
tests were not statistically significant.
In the multivariate analysis, we assessed the effects 
of various factors on the adequacy of the 25(OH)D 
concentration (≥ 30 ng/mL) by using logistic regres-
sion. The response variable was the adequacy of vi-
tamin D status. The explanatory variables we tested 
were age, ClCr, BMI, skin phototype, SI, fat mass, the 
cholecalciferol dose, the month of the blood draw and 
physical activity. Only the cholecalciferol dose, phy-
sical exercise and the month of the blood draw were 
significantly associated with the adequacy of vitamin 
D status. According to the final model, those who en-
gaged in physical activity were 2.12 times more likely 
to have a serum 25(OH)D concentration ≥ 30 ng/
mL compared with those who did not; those who had 
their blood drawn in September were 2.52 times more 
likely to have a serum 25(OH)D concentration ≥ 30 
ng/mL than those who did not. Furthermore, the fi-
nal model showed that the chance of having adequa-
te vitamin D status increased by 12% for each 1,000 
IU/week increase in the dosage of cholecalciferol. To 
better understand the relationship between the abo-
ve mentioned explanatory variables and the concen-
tration of 25(OH)D, we used the decision tree method 
(Figure 2). We could confirm the association between 
the cholecalciferol dose and physical activity and hi-
gher 25(OH)D concentrations. The patients who 
were taking a cholecalciferol dose ≤ 6,986 IU/week 
had a mean 25(OH)D concentration of 20.2 ng/mL. 
Physical activity was associated with improvement 
when the patient had a suboptimal 25(OH)D mean 
value (Node 2, Figure 2). Node 3 (Figure 2) indicated 
that 29 patients were taking a cholecalciferol dose > 
14,000 IU/week; in this group, the mean 25(OH)
D concentration was 32.7 ng/mL. The participants 
who did not engage in physical activity did not differ 
significantly from those who were physically active in 
terms of age, sex, BMI, functional abilities, comorbid 
conditions or treatment.
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Cholecalciferol IU/week
Adj. P-value = 0.000, F = 16.543,
df1 = 2, df2 = 360
Table 3. Factors related to higher levels of 25(OH)D in the study population
Variable Test
25(oH)D
p mean ± SD n
Physical activity Student’s t 0.033 24.8 ± 11.3 363
Yes t = 2.15 (B)26.3 ± 10.1 155
No (A)23.7 ± 11.9 208
Frequency of physical activity Kruskal-Wallis 0.007 24.8 ± 11.3 363
No (A)23.7 ± 11.9 208
1-2 times (B)27.9 ± 10.4 62
3-5 times 25.3 ± 9.7 66
More than 6 times 25.0 ± 10.3 27
Vitamin D supplementation Student’s t < 0.001 24.8 ± 11.3 363
Yes t = 3.88 (B)25.9 ± 11.2 296
No (A)20.1 ± 10.5 67
Smoking Student’s t 0.042 24.8 ± 11.3 363
Yes t = 2.04 (A)21.4 ± 7.9 40
No (B)25.2 ± 11.6 323
month of the blood draw Kruskal-Wallis 0.026 24.8 ± 11.3 363
June (B)27.0 ± 12.6 78
July 24.2 ± 11.1 61
August (A)22.8 ± 9.4 140
September (B)28.3 ± 12.7 49
October/November/December 24.4 ± 11.9 35
PTH Student’s t #0.022 24.8 ± 11.3 363
< 15 pg/mL t = 2.31 32.4 ± - 1
15-65 pg/mL (B)25.6 ± 11.3 263
> 65 pg/mL (A)22.6 ± 10.9 99
(A) and (B) means are different at the 5% level of significance. # Comparison between the groups “PTH 15-65” and “PTH > 65”.
Node 0
Mean 24.808 (SD ± 11.27)
n = 363 (100%)
Node 1
Mean 20.207 (SD ± 9.544)
n = 91 (25.1%)
Node 4
Mean 27.541 (SD ± 10.391)
n = 110 (30.3%)
Node 5
Mean 23.982 (SD ± 10.057)
n = 133 (36.6%)
Node 2
Mean 25.593 (SD ± 10.342)
n = 243 (66.9%)
Node 3
Mean 32.672 (SD ± 16.935)
n = 29 (8.0%)
25(OH)D ng/mL
≤ 6986 IU
Yes No
6986, 14000 IU > 14000 IU
Physical activity
Adj. P-value = 0.007, F = 7.316,
df1 = 1, df2 = 241
Figure 2. Decision tree: modifiable factors of vitamin D status in the study population.
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DISCuSSIoN
Our research covered osteoporotic patients who were 
seeking secondary care in a public health-care setting. 
The participants had characteristics similar to the ge-
neral population of the São Paulo metropolitan area 
(SPMA) (25-29). The SPMA is located at 23°S and 
46°W in southeastern Brazil with a population over 
19 million; 11.3% of the people are over 60 (30). The 
region has approximately 2,000 industries with high 
pollution potential and a fleet of more than 8.4 million 
vehicles (30). A low level of 25(OH)D is highly pre-
valent in the Brazilian population in various regions of 
the country (31,32), even in areas closer to the equa-
tor (33). However, the high prevalence of inadequate 
vitamin D status in our sample – 36% had vitamin D 
status < 20 ng/mL, and 73% had vitamin D status < 
30 ng/mL – was unexpected, considering that 81.5% 
of the subjects were receiving supplemental vitamin D 
(the mean cholecalciferol dose was 8,169 IU/week). 
“The Brazilian Osteoporosis Study” (BRAZOS) reve-
aled low dietary intake of vitamin D (80 IU/day) and 
calcium (~400 mg/day) in southeastern Brazil (34). 
Although their intake was still inadequate (34,35), our 
population showed a higher dietary intake of vitamin 
D (~170 IU/day) and calcium (~800 mg/day). It is 
possible to credit this difference to the fact that our 
population is composed of osteoporotic patients who 
most likely received nutritional guidance to consume 
these nutrients.
In our public outpatient clinic, 25(OH)D blood test 
is not routinely available, and the prescription of chole-
calciferol may vary based on the clinical assessment of the 
patient. However, most commonly, we adopt standardi-
zed weekly doses of 7,000 IU or 14,000 IU (1,35). It 
is important to remember that the mean cholecalciferol 
dose was 13,185 IU/week for the participants who re-
ceived vitamin D supplementation and had adequate vi-
tamin D status. The decision tree showed that the 29 pa-
tients who were receiving a cholecalciferol dose > 14,000 
IU/week achieved a mean 25(OH)D concentration > 
30 ng/mL, which is considered a desirable 25(OH)D 
concentration in terms of PTH levels and health outco-
mes by most experts (8,36). These findings corroborate 
the observations of other authors (11,35,37-39) and in-
dicate that even in a sunny country such as Brazil, higher 
supplemental vitamin D doses may be necessary to gua-
rantee adequate vitamin D status (11).
As shown by others (6,32,33,38), the 25(OH)D con-
centration was positively correlated with BMD and nega-
tively correlated with PTH in our research. This positive 
effect on BMD (FN) could be a consequence of a decre-
ase in the PTH concentrations of the patients with higher 
levels of 25(OH)D (6). Because secondary hyperpara-
thyroidism stimulates bone loss and increases the risk of 
fractures (6), these observations may be clinically relevant, 
particularly for patients in treatment for osteoporosis. 
The majority of subjects were evaluated during the 
winter, which might have contributed to the lack of a 
relationship between the 25(OH)D concentration and 
the sun exposure index, which has also been observed 
by other authors (40). We can also speculate that the 
lack of a relationship between sun exposure index and 
25(OH)D may be explained by the fact that our popu-
lation, which has relative homogeneity, lives in a region 
where air quality exceeds the standards for several days 
out of the year, and air pollution can adversely affect 
vitamin D production in the skin (5,30,41). 
We found that higher 25(OH)D concentrations 
were associated with various parameters, including not-
-smoking, physical activity, the month of the blood 
draw and the use of cholecalciferol. However, in the 
multivariate analysis, only the supplemental dose of vi-
tamin D, physical activity and the month of the blood 
draw remained associated with higher 25(OH)D con-
centrations. Other authors have also observed lower 
25(OH)D concentrations in smokers (10,42). Althou-
gh a negative correlation between the 25(OH)D con-
centration and obesity has been observed by various 
authors (5,8,43), this result was not produced in our 
study and others (44). The majority of the participants 
had BMI between 18.5 and 29.9 kg/m2 (median 25.6 
kg/m2), whereas only 13.5% had BMI ≥ 30 kg/m2. In 
our study, this relative homogeneity of the population 
and the small number of participants with extreme weight 
values (BMI < 18.5 kg/m2 and ≥ 30 kg/m2) might 
have contributed to the lack of a relationship between 
the 25(OH)D concentration and obesity (44). 
The engagement in physical activity increased the 
odds of having adequate vitamin D status 2.12 times. 
This association does not necessarily indicate causality, 
but physical activity has been associated with higher le-
vels of 25(OH)D in various studies (9,10,45,46). One 
could bear in mind that higher levels of serum 25(OH)
D may promote a sense of well-being and increase one’s 
willingness to engage in physical activity. On the other 
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hand, people who exercise tend to be outside more fre-
quently and are more active, which leads to greater sun 
exposure. Interestingly, in our study, no relationship be-
tween sun exposure index and 25(OH)D was observed. 
We certainly do not intend to question the importance of 
sun exposure in the production of vitamin D, given that 
our results showed that the season had an influence on 
serum 25(OH)D concentration. As expected, the serum 
25(OH)D concentrations were lower in August (the end 
of winter), and the patients’ blood tests in September 
(the beginning of spring) were more likely to show an 
adequate serum 25(OH)D concentration (OR = 2.52). 
However, our results indicated that physical activity was 
a factor associated with improved vitamin D status even 
after controlling for the month of the blood draw (in the 
logistic regression analysis). Thus, we could hypothesi-
ze that exercise independently modifies 25(OH)D levels 
(46). Cholecalciferol is fat-soluble and stored in body fat 
depots. As physical activity promotes weight loss, the sto-
red cholecalciferol may be released, which leads to an in-
creased 25(OH)D concentration (44). Exercise increases 
energy expenditure and activates thermogenic function 
in adipose tissues. Recently, in animal studies, irisin was 
described; this hormone, which is secreted by muscle, 
has powerful effects on the browning of white adipose 
tissues and activates thermogenic function in adipose 
tissue (47). Perhaps these effects promote a decrease in 
the uptake of vitamin D by adipose tissue (reducing adi-
pose stores), enhancing the circulating vitamin D levels. 
Another hypothesis is that an increase in serum 25(OH)
D may be linked with increased muscle usage and the 
release of 25(OH)D from the muscle tissue itself. More 
recently, in animal studies, it was shown that after up-
take into mature muscle cells, 25(OH)D is held there 
by vitamin D binding protein. This sequestration by the 
skeletal muscle could protect 25(OH)D from hepatic de-
gradation and thus could provide a functional store to 
maintain vitamin D status (48). However, more data are 
needed to clarify these complex relationships.
CoNCLuSIoNS
In this osteoporotic population, the prevalence of ina-
dequate vitamin D status was high (73.3%). We found 
that vitamin D supplementation of 7,000 IU/week 
was not enough to reach the desired 25(OH)D con-
centration (≥ 30 ng/mL), and our findings suggest 
that doses ≥ 14,000 IU/week seem optimal. These 
findings reinforce the need for laboratory assessments 
of 25(OH)D concentration, even in sunny countries 
such as Brazil, at least for higher-risk patients such 
as osteoporotic patients. Lower serum 25(OH)D 
concentrations were found at the end of the winter 
(August), and engaging in physical exercise could be 
a factor in improving vitamin D status. These obser-
vations may be useful for planning public health stra-
tegies for improving vitamin D status in the general 
population.
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